David A. Mankoff
Nuclear Medicine
Nuclear Medicine & Clinical Molecular Imaging, 1 Donner, 3400 Spruce Street
Philadelphia, PA 19104
Philadelphia, PA 19104
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 194 publications
Navigating the path: Advice to physician-scientists on choosing a clinical specialty.
Journal: eLife
Published: July 03, 2026
Response to the Comment on "Negative 18 F-FES PET/CT Despite Estrogen Receptor Positivity By Immunohistochemistry."
Journal: Clinical nuclear medicine
Published: April 07, 2026
Prospective exploratory pilot study of 18 F-FMISO PET/CT for assessing tumor hypoxia in soft tissue sarcomas.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: December 18, 2025
Creating a dedicated radionuclide therapy clinic and leveraging telemedicine to increase access to radiopharmaceutical therapies.
Journal: Clinical imaging
Published: November 12, 2025
A Call for High-Level Evidence Before Routine Implementation of Posttreatment SPECT.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 04, 2025
Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent Glioblastoma.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 29, 2025
[ 18 F]Fluoroestradiol Uptake in Benign Nodular Sclerosing Adenosis of the Breast.
Journal: Clinical nuclear medicine
Published: October 13, 2025
EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial).
Journal: Future oncology (London, England)
Published: October 06, 2025
CLEAR: an auditable foundation model for radiology grounded in clinical concepts.
Journal: Nature biomedical engineering
Published: September 26, 2025
First-in-Human Biodistribution and Dosimetry of [11C]Trimethoprim.
Journal: Molecular imaging and biology
Published: July 27, 2025
Residual Breast Cancer Cells Co-opt SOX5-driven Endochondral Ossification to Maintain Dormancy.
Journal: bioRxiv : the preprint server for biology
Published: July 14, 2025
Last Updated: 09/26/2026